DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative Women
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01874158|
Recruitment Status : Completed
First Posted : June 10, 2013
Last Update Posted : December 19, 2016
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||99 participants|
|Official Title:||DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative Women|
|Study Start Date :||November 2012|
|Actual Primary Completion Date :||April 2014|
|Actual Study Completion Date :||April 2014|
TV postive women
All women who are TV positive by wet prep or in-pouch and meet the inclusion exclusion requirements.
- TV negative by PCR, post treatment [ Time Frame: 4 weeks ]Women are assessed for TV at each weekly visit by PCR. They are considered cleared of the remnant DNA after PCR is negative.
Biospecimen Retention: Samples With DNA
1 vaginal swab collected at screening for In-pouch 3 vaginal swabs collected at enrollment, PCR, gram stain, and future microbiome study At each of 3 follow-up visits, 3 vaginal swabs, PCR, In-pouch, and future microbiome study At the 4th follow-up visit, 4 vaginal swabs, PCR, In-pouch, gram stain, and future microbiome study.
All swabs, except at screening, are self-collected.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01874158
|United States, Louisiana|
|Delgado Personal Health Center|
|New Orleans, Louisiana, United States, 70112|
|Principal Investigator:||Patricia J Kissinger, PhD||Tulane University School of Public Health and Tropical Medicine|